TEMPORARY CORNEAL REPAIR (TCR) PROGRAM, AND WILL SUPPORT FOOD AND DRUG ADMINISTRATION (FDA) CLEARANCE/APPROVAL OF A TEMPORARY, NON-SURGICAL SOLUTION TO CLOSE OPEN GLOBE, FULL THICKNESS CORNEAL WOUNDS. THIS SPECIFIC CONTRACT ACTION IS FOR POTENTIAL DEVELOPERS TO ENGAGE THE FDA, CONDUCT GLP ANIMAL STUDIES, AND DELIVER PROTOTYPE DEVICES TO THE GOVERNMENT.

Awarded to ASHVATTHA THERAPEUTICS, LLC · CAGE 7UG21

Reported totals are cumulative values from the latest available award record. Observed obligations and actions reflect Mimir's FY2019 onward transaction window and may omit earlier activity.